How did BCYC's Q1 2024 EPS surprise analysts?
4/7/2025 04:36pm
Bicycle Therapeutics (BCYC) reported an EPS surprise of $0.62 for Q1 2024, which was a significant positive surprise compared to analysts' expectations. This indicates that the company's performance for the quarter exceeded analysts' forecasts, potentially due to factors such as strong revenue growth, cost management, or operational efficiencies.
|code|Ticker|Name|Date|EPS Surprise|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|BCYC|BCYC.O|Bicycle Therapeutics|2023 Q2|-0.12|-1.41|185|
|BCYC|BCYC.O|Bicycle Therapeutics|2023 Q3|-0.09|-1.26|185|
|BCYC|BCYC.O|Bicycle Therapeutics|2023 Q4|0.07||185|
|BCYC|BCYC.O|Bicycle Therapeutics|2024 Q1|0.62|-0.62|185|